28. märts 2007
Tähelepanu! Artikkel on enam kui 5 aastat vana ning kuulub väljaande digitaalsesse arhiivi. Väljaanne ei uuenda ega kaasajasta arhiveeritud sisu, mistõttu võib olla vajalik kaasaegsete allikatega tutvumine.
Bayer enters final phase of Schering integration in the Baltics
Tallinn- Estonia- 2007 March 29
<br />On March 27 the existing branch and representative offices of BayerOY and UAB Scher-ing in Lithuania- Latvia and Estonia have beenlegally combined. The new organisation will carry the name UAB"Bayer". With this important milestone in place- Bayer is enter-ingthe final phase of integration in the Baltic states.
"The combination of Bayer and Schering will strengthen ourposition in the markets we serve in Baltics"- said Anti Sainast-General Manager of UAB "Bayer". "With our portflio of innovativeproducts such as Betaferon- Ultravist- Yarina- Yasminelle- Mirena-Andro-cur- Fludara- Nexavar- Advantan- Pritor- we are committed toproviding the highest level of service to our customers".
Liitu Meditsiiniuudiste uudiskirjaga!